AR248350A1 - Metodo para preparar una tableta de aminoguanidina de compresion directa. - Google Patents
Metodo para preparar una tableta de aminoguanidina de compresion directa.Info
- Publication number
- AR248350A1 AR248350A1 AR93324726A AR32472693A AR248350A1 AR 248350 A1 AR248350 A1 AR 248350A1 AR 93324726 A AR93324726 A AR 93324726A AR 32472693 A AR32472693 A AR 32472693A AR 248350 A1 AR248350 A1 AR 248350A1
- Authority
- AR
- Argentina
- Prior art keywords
- aminoguanidine
- rocio
- drying
- drying process
- spray drying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UN METODO PARA PREPARAR UNA TABLETA DE AMINOGUANIDINA DE COMPRESION DIRECTA, QUE COMPRENDE ENTRE EL 50% Y EL 99% DE AMINOGUANIDINA O UNA DE SUS SALES, QUE COMPRENDE LAS SIGUIENTES ETAPAS: COMBINAR AMINOGUANIDINA O UNA DE SUS SALES, UNA CANTIDAD SUFICIENTE DE UNA SOLUCION ACUOSA CAPAZ DE DISOLVER LA AMINOGUANIDINA Y UNA CANTIDAD SUFICIENTE DE UN AGLUTINANTE COMPATIBLE CON LA SOLUCION DE AMINOGUANIDINA; SOMETER A SECADO DE ROCIO LA SOLUCION DE AMINOGUANIDINA EN UNA CAMARA DISECADORA EN CONDICIONES SUFICIENTES PARA OBTENER UN POLVO SECADO DE ROCIO ADECUADO PARA COMPRESION DIRECTA EN TABLETAS; Y COMPRIMIR SUFICIENTEMENTE EL POLVO OBTENIDO POR SECADO DE ROCIO EN UNA TABLETA COMPRIMIDA PARA ADMINISTRACION A UN PACIENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86955892A | 1992-04-15 | 1992-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR248350A1 true AR248350A1 (es) | 1995-08-18 |
Family
ID=25353792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR93324726A AR248350A1 (es) | 1992-04-15 | 1993-04-13 | Metodo para preparar una tableta de aminoguanidina de compresion directa. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5534551A (es) |
| EP (1) | EP0636023B1 (es) |
| JP (1) | JPH07505654A (es) |
| KR (1) | KR950700730A (es) |
| AR (1) | AR248350A1 (es) |
| AT (1) | ATE183086T1 (es) |
| AU (1) | AU665678B2 (es) |
| CA (1) | CA2118133C (es) |
| DE (1) | DE69325996T2 (es) |
| DK (1) | DK0636023T3 (es) |
| ES (1) | ES2136659T3 (es) |
| FI (1) | FI944855A0 (es) |
| GR (1) | GR3031486T3 (es) |
| HU (1) | HUT70870A (es) |
| IL (1) | IL105363A (es) |
| MX (1) | MX9302153A (es) |
| NO (1) | NO943899L (es) |
| NZ (1) | NZ251806A (es) |
| TW (1) | TW261538B (es) |
| WO (1) | WO1993020808A1 (es) |
| ZA (1) | ZA932595B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093745A (en) * | 1997-11-25 | 2000-07-25 | Psorx, L.L.C. | Methods and composition for treating skin proliferative diseases |
| US6294198B1 (en) | 1999-08-24 | 2001-09-25 | Purepac Pharmaceutical Co. | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same |
| US20030206978A1 (en) * | 2001-11-29 | 2003-11-06 | Bob Sherwood | Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose |
| US20040086566A1 (en) * | 2002-11-04 | 2004-05-06 | Alpharma, Inc. | Waxy matrix dosage forms |
| DE202013102188U1 (de) | 2013-05-17 | 2013-06-12 | Che-An Tsai | Anordnung einer trocken aufhängbaren Dünnstein-Wandbauplatte |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3621056A (en) * | 1968-08-16 | 1971-11-16 | Sandoz Ag | Substituted benzylideneamino guanidines |
| DE2015321A1 (en) * | 1969-04-04 | 1970-10-08 | Sandoz Ag, Basel (Schweiz) | Novel guanidine derivs |
| US3714363A (en) * | 1970-08-11 | 1973-01-30 | Sandoz Ag | Substituted amino guanidine as anti-diabetic agents |
| US3659016A (en) * | 1971-04-26 | 1972-04-25 | Sandoz Ag | Substituted amino guanidines as anti-obesity agents |
| NL7317772A (es) * | 1973-01-04 | 1974-07-08 | ||
| DE2736064A1 (de) * | 1977-08-10 | 1979-02-22 | Bayer Ag | Antimalaria-mittel |
| US4374082A (en) * | 1981-08-18 | 1983-02-15 | Richard Hochschild | Method for making a pharmaceutical and/or nutritional dosage form |
| DE3135329A1 (de) * | 1981-09-05 | 1983-03-24 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen |
| US4533674A (en) * | 1983-10-24 | 1985-08-06 | Basf Wyandotte Corporation | Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid |
| US4605666A (en) * | 1983-10-24 | 1986-08-12 | Basf Corporation | Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby |
| US4758583A (en) * | 1984-03-19 | 1988-07-19 | The Rockefeller University | Method and agents for inhibiting protein aging |
| US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
| US4916163A (en) * | 1985-06-04 | 1990-04-10 | The Upjohn Company | Spray-dried lactose formulation of micronized glyburide |
| US4710519A (en) * | 1985-09-30 | 1987-12-01 | Basf Corporation | Process for preparing spray dried acetaminophen powder and the powder prepared thereby |
| US4892889A (en) * | 1986-11-18 | 1990-01-09 | Basf Corporation | Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin |
| EP0339496A3 (en) * | 1988-04-26 | 1991-05-08 | Ono Pharmaceutical Co., Ltd. | Aminoguanidine derivatives |
| US5077313A (en) * | 1988-11-25 | 1991-12-31 | Gert Lubec | Process for inhibiting pathological collagen cross-linking in diabetes patients |
| US5002774A (en) * | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
| PT96229B (pt) * | 1989-12-22 | 1998-06-30 | Syntex Pharma Int | Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico |
-
1993
- 1993-03-24 HU HU9402981A patent/HUT70870A/hu unknown
- 1993-03-24 AT AT93909154T patent/ATE183086T1/de active
- 1993-03-24 JP JP5518346A patent/JPH07505654A/ja active Pending
- 1993-03-24 US US08/318,754 patent/US5534551A/en not_active Expired - Fee Related
- 1993-03-24 DE DE69325996T patent/DE69325996T2/de not_active Expired - Fee Related
- 1993-03-24 WO PCT/US1993/002714 patent/WO1993020808A1/en active IP Right Grant
- 1993-03-24 AU AU39667/93A patent/AU665678B2/en not_active Ceased
- 1993-03-24 NZ NZ251806A patent/NZ251806A/en unknown
- 1993-03-24 DK DK93909154T patent/DK0636023T3/da active
- 1993-03-24 ES ES93909154T patent/ES2136659T3/es not_active Expired - Lifetime
- 1993-03-24 EP EP93909154A patent/EP0636023B1/en not_active Expired - Lifetime
- 1993-03-24 CA CA002118133A patent/CA2118133C/en not_active Expired - Fee Related
- 1993-04-10 TW TW082102697A patent/TW261538B/zh active
- 1993-04-13 ZA ZA932595A patent/ZA932595B/xx unknown
- 1993-04-13 AR AR93324726A patent/AR248350A1/es active
- 1993-04-13 IL IL105363A patent/IL105363A/xx not_active IP Right Cessation
- 1993-04-14 MX MX9302153A patent/MX9302153A/es not_active IP Right Cessation
-
1994
- 1994-10-14 NO NO943899A patent/NO943899L/no unknown
- 1994-10-14 KR KR1019940703653A patent/KR950700730A/ko not_active Application Discontinuation
- 1994-10-14 FI FI944855A patent/FI944855A0/fi unknown
-
1999
- 1999-10-08 GR GR990402579T patent/GR3031486T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL105363A0 (en) | 1993-08-18 |
| JPH07505654A (ja) | 1995-06-22 |
| GR3031486T3 (en) | 2000-01-31 |
| ATE183086T1 (de) | 1999-08-15 |
| TW261538B (es) | 1995-11-01 |
| HU9402981D0 (en) | 1995-02-28 |
| EP0636023A1 (en) | 1995-02-01 |
| ES2136659T3 (es) | 1999-12-01 |
| MX9302153A (es) | 1994-05-31 |
| EP0636023B1 (en) | 1999-08-11 |
| AU665678B2 (en) | 1996-01-11 |
| FI944855A (fi) | 1994-10-14 |
| IL105363A (en) | 1997-07-13 |
| NO943899L (no) | 1994-12-14 |
| NO943899D0 (no) | 1994-10-14 |
| US5534551A (en) | 1996-07-09 |
| NZ251806A (en) | 1996-01-26 |
| DK0636023T3 (da) | 1999-12-06 |
| AU3966793A (en) | 1993-11-18 |
| WO1993020808A1 (en) | 1993-10-28 |
| FI944855A0 (fi) | 1994-10-14 |
| CA2118133C (en) | 1997-01-21 |
| DE69325996D1 (de) | 1999-09-16 |
| HUT70870A (en) | 1995-11-28 |
| DE69325996T2 (de) | 1999-12-23 |
| ZA932595B (en) | 1993-10-26 |
| KR950700730A (ko) | 1995-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES430431A1 (es) | Varistor de oxido metalico. | |
| DE3868077D1 (de) | Therapeutisches system fuer schwerloesliche wirkstoffe. | |
| DE3271829D1 (en) | An allergen dry powder composition and process for its preparation | |
| ES2176565T3 (es) | Agente auxiliar para la formacion directa de comprimidos. | |
| ES2060825T3 (es) | Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa. | |
| AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
| MD872G2 (ro) | Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului | |
| NO813826L (no) | Smertenedbrytende legemiddel-presslegemer | |
| AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
| ATE83651T1 (de) | Acetylcystein enthaltende mundloesliche arzneimittel. | |
| AR248350A1 (es) | Metodo para preparar una tableta de aminoguanidina de compresion directa. | |
| DE69427981D1 (de) | Verkapselter arzneistoff | |
| ATE107853T1 (de) | Orales, melatonin enthaltendes arzneimittel. | |
| ATE404214T1 (de) | Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält | |
| NZ237513A (en) | Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof | |
| KR930702004A (ko) | 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법 | |
| GB2021409A (en) | Pharmaceutical composition | |
| FI963567A (fi) | Diklofenakki-Na:a sisältävä depottabletti | |
| ES2154744T3 (es) | Formulaciones de comprimidos farmaceuticos para compresion directa. | |
| FR2106566A1 (en) | Tabletting active materials - by compressing encapsulated particles | |
| GB1355985A (en) | Solid slow release preparation of prolonged action | |
| GB1460302A (en) | Tablet formulation | |
| GB1480441A (en) | Compositions for treating nicotine poisoning | |
| ES419603A1 (es) | Procedimiento para la produccion de tabletas mecanicamente estables y resistentes que contienen una o varias pirazolo- nas y eventualmente compuestos de cafeina. | |
| GB1263839A (en) | A novel aminoethanesulfonic acid |